Fixed Prosthodontic Treatment Outcomes in the Long-Term Management of Patients with Periodontal Disease: A 20-Year Follow-Up Report

2016 ◽  
Vol 28 (3) ◽  
pp. 246-251 ◽  
Author(s):  
Gianfranco Di Febo ◽  
Attilio Bedendo ◽  
Federica Romano ◽  
Francesco Cairo ◽  
Gianfranco Carnevale
Keyword(s):  
Periodontal Disease ◽  
Treatment Outcomes ◽  
Term Management

Long-Term Treatment Outcomes for Heroin Dependence: The 11-Year Follow-Up of the ATOS Study

2013 ◽  
Author(s):  
Christina Marel ◽  
Maree Teesson ◽  
Shane Darke ◽  
Katherine Mills ◽  
Joanne Ross ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Term Treatment ◽  
Heroin Dependence ◽  
Long Term Treatment

scholarly journals Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities

2018 ◽  
Vol 3 (5) ◽  
pp. e001018 ◽  
Author(s):  
Ramnath Subbaraman ◽  
Laura de Mondesert ◽  
Angella Musiimenta ◽  
Madhukar Pai ◽  
Kenneth H Mayer ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Healthcare Providers ◽  
Research Priorities ◽  
Directly Observed Therapy ◽  
Loss To Follow Up ◽  
Individualised Care ◽  
Health System Efficiency ◽  
Tuberculosis Therapy

Poor medication adherence may increase rates of loss to follow-up, disease relapse and drug resistance for individuals with active tuberculosis (TB). While TB programmes have historically used directly observed therapy (DOT) to address adherence, concerns have been raised about the patient burden, ethical limitations, effectiveness in improving treatment outcomes and long-term feasibility of DOT for health systems. Digital adherence technologies (DATs)—which include feature phone–based and smartphone-based technologies, digital pillboxes and ingestible sensors—may facilitate more patient-centric approaches for monitoring adherence, though available data are limited. Depending on the specific technology, DATs may help to remind patients to take their medications, facilitate digital observation of pill-taking, compile dosing histories and triage patients based on their level of adherence, which can facilitate provision of individualised care by TB programmes to patients with varied levels of risk. Research is needed to understand whether DATs are acceptable to patients and healthcare providers, accurate for measuring adherence, effective in improving treatment outcomes and impactful in improving health system efficiency. In this article, we describe the landscape of DATs that are being used in research or clinical practice by TB programmes and highlight priorities for research.

scholarly journals Periodontitis subject with failing dentition and management with cross arch bridge and implants

2016 ◽  
Vol 2 (3) ◽  
pp. 58
Author(s):  
Farhan Durrani
Keyword(s):  
Periodontal Disease ◽  
Tooth Loss ◽  
Disease Recurrence ◽  
Prosthetic Rehabilitation ◽  
Long Term Follow Up ◽  
Full Mouth Rehabilitation ◽  
Severe Periodontal Disease ◽  
Arch Bridges

<p class="abstract"><span lang="EN-US">Severe periodontal disease often leads to tooth loss, necessitating prosthetic rehabilitation to restore function and aesthetics. The concept of perio-prosthetic treatment using extensive bridges of cross-arch design was introduced approximately 30 years ago. Long term follow-up studies have shown that teeth with reduced periodontal support can be used as abutments for extensive fixed prostheses, provided periodontal disease had been treated successfully and an effective recall program had been instituted to prevent periodontal disease recurrence. Implants along with cross arch bridges in controlled periodontitis subject have never been used together for complete full mouth rehabilitation.</span></p>

Treatment of cystoid macular oedema secondary to pentosan polysulfate maculopathy using anti-VEGF and intravitreal steroid injections

2021 ◽  
pp. 112067212110663
Author(s):  
Samantha Roshani De Silva ◽  
Isuru De Silva ◽  
Bishwanath Pal
Keyword(s):  
Treatment Outcomes ◽  
Macular Oedema ◽  
Therapeutic Options ◽  
Cystoid Macular Oedema ◽  
Pentosan Polysulfate ◽  
Steroid Injections ◽  
Anti Vegf ◽  
Drug Cessation

Background Pentosan polysulfate-related maculopathy is a recently described clinical entity, related to dose and long term use of this medication, and may progress despite drug cessation. Cystoid macular oedema (CMO) has been reported in some cases, but there are few reports of treatment outcomes in the literature. Aims We present the case of a 55 year old female, with CMO secondary to pentosan polysulfate maculopathy, that was responsive to treatment with both intravitreal anti-VEGF and steroid injections, stabilising vision over a four year follow up period. Conclusions This is the first report, to our knowledge, of CMO related to pentosan polysulfate maculopathy responding to intravitreal steroid injections, broadening the therapeutic options for preserving vision in these patients.

scholarly journals Treatment of penile lichen sclerosus with topical corticosteroids for over 25 years’ duration: A case report

2018 ◽  
Vol 6 ◽  
pp. 2050313X1879504 ◽  
Author(s):  
Matthew Howard ◽  
Anthony Hall
Keyword(s):  
Case Report ◽  
Relevant Literature ◽  
Lichen Sclerosus ◽  
Short Review ◽  
Short Term ◽  
Topical Corticosteroids ◽  
Long Term Follow Up ◽  
Term Management

Topical corticosteroids are currently recommended only for short-term management of flares of lichen sclerosus, with efficacy in halting disease progression. Given the chronic nature of this condition, there is a lack of literature surrounding the chronic effects of topical corticosteroids on the male genitalia with many dermatologists avoiding prescribing long term. This case report aims to provide anecdotal observation for the long-term use of topical corticosteroids and details the long-term follow-up of an individual who used potent and superpotent topical corticosteroids for over 25 years without significant demonstrable side effects. A short review on relevant literature is provided.

Changes in Visual Acuity and Refraction in the Exfoliation Syndrome. A Five-Year Follow-up Study

2001 ◽  
Vol 11 (3) ◽  
pp. 245-251 ◽  
Author(s):  
P.M. Puska ◽  
A.H.A. Tarkkanen
Keyword(s):  
Visual Acuity ◽  
Main Type ◽  
Exfoliation Syndrome ◽  
Follow Up Study ◽  
Exfoliative Glaucoma ◽  
The Difference ◽  
Term Management ◽  
Fellow Eyes

Purpose To examine changes in visual acuity (VA) and refraction in non-glaucomatous patients with unilateral exfoliation syndrome (EXS). Methods The best corrected values for VA (Snellen acuity cards) subjectively adjusted for refraction, and IOP were measured, and the development of lens opacities was examined in 46 non-glaucomatous patients with unilateral EXS. Results After five years the rate of conversion to bilateral exfoliation was 22% and to exfoliative glaucoma 30%. There was a significant decrease in VA in the exfoliative (E) eyes (median; QI, QIII, range: 1; 0.8, 1, 0.4-1.3 vs. 0.55; 0.4, 1, 0.05-1.4, p<0.0001) and the fellow, initially non-exfoliative (NE), eyes (1; 0.9, 1, 0.3–1.3 vs. 0.7; 0.5, 0.9, 0.1–1.4, p<0.0001) and a significant myopic change in refraction in the E eyes (+1.02 ± 2.48 vs. +0.11 ± 3.06, p=0.0001) and the NE eyes (+0.99 ± 2.25 vs. +0.43 ± 2.55 D, p<0.01). At study entry the difference in refraction between the fellow eyes (refraction in the NE eye – refraction in the E eye) was −0.27 ± 1.00D. After five years it was +0.32 ± 1.44 (p 0.016), reflecting greater myopic changes in the E eyes. The main type of lens opacification was nuclear sclerosis. Conclusions In five years, significant decreases in VA and myopic shifts in refraction occurred in the E and fellow eyes. The E eyes showed significantly greater myopic changes than the fellow eyes; the cause was clearly nuclear sclerosis, which must be taken into account in the long-term management of patients with EXS.

Sign in / Sign up

Export Citation Format

Share Document